ResearcherUniversity of PalermoNo recent work listed
Rosario Mazzola
Matched on ORCID iD 0000-0002-2838-7337; OpenAlex author ID A5044173595. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 4
- Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy. Co-author DOI 10.1007/s11547-021-01422-z↗
- Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery. Co-author DOI 10.1007/s00066-018-1306-2↗
- Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body Radiation Therapy" [Critical Reviews in O… Co-author DOI 10.1016/j.critrevonc.2016.12.010↗
- Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy. Co-author DOI 10.1016/j.critrevonc.2016.05.003↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Filippo Alongi · 4 shared papers, 2016–2022 · strength 0.35
- Paper Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiat… DOI 10.1007/s11547-021-01422-z↗
- Paper Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose … DOI 10.1007/s00066-018-1306-2↗
- Paper Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body R… DOI 10.1016/j.critrevonc.2016.12.010↗
- Fabiana Gregucci · 2 shared papers, 2018–2022 · strength 0.21
- Paper Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiat… DOI 10.1007/s11547-021-01422-z↗
- Paper Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose … DOI 10.1007/s00066-018-1306-2↗
- Berardino De Bari · 2 shared papers, 2016–2017 · strength 0.14
- Paper Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body R… DOI 10.1016/j.critrevonc.2016.12.010↗
- Paper Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation the… DOI 10.1016/j.critrevonc.2016.05.003↗
- Mahmut Özşahin · 2 shared papers, 2016–2017 · strength 0.14
- Paper Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body R… DOI 10.1016/j.critrevonc.2016.12.010↗
- Paper Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation the… DOI 10.1016/j.critrevonc.2016.05.003↗
- Markus Schäfer · 2 shared papers, 2016–2017 · strength 0.14
- Paper Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body R… DOI 10.1016/j.critrevonc.2016.12.010↗
- Paper Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation the… DOI 10.1016/j.critrevonc.2016.05.003↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.